Company intelligence / Profile preview

Anaconda Biomed

Sant Quirze del Vallès / Barcelona, Catalonia, Spainanaconda.bio ↗

Ownership: Private
Employees: ~23
Development stage: Preclinical

Overview

Anaconda Biomed has developed the ANA Funnel Catheter system for mechanical thrombectomy in acute ischemic stroke. The device has demonstrated promising results in vitro and in vivo studies as well as initial human clinical experience. The company is currently conducting a pivotal randomized clinical trial with over 300 patients across Europe and the US to support regulatory submissions for CE Marking and FDA approval.

Therapeutic areas: Neurology
Modalities: Device (specifically, mechanical thrombectomy catheter)
Industry: Surgical Medical Devices

Drug pipeline

2 assets

ANA System

Pre-clinical

Indications: Acute ischemic stroke

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Anaconda Biomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anaconda Biomed.

Explore the full profile